ORIGINAL RESEARCH
Published on 18 Feb 2025
Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database
doi 10.3389/fphar.2025.1459067
- 130 views
- Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Research Topics
- Advances in Drug-induced Diseases Volume II
Advances in Drug-induced Diseases Volume II
24k
Total downloads
111k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 13 Feb 2025
Signal Detection and Safety Analysis of Three Tyrosine Kinase Inhibitors for HER-2 Positive Breast Cancer: A Retrospective Study Based on the FAERS Database
doi 10.3389/fphar.2025.1538881
ORIGINAL RESEARCH
Published on 13 Feb 2025
Real-world pharmacovigilance investigation of imipenem/cilastatin: signal detection using the FDA Adverse Event Reporting System (FAERS) database
doi 10.3389/fphar.2025.1524159
- 125 views
ORIGINAL RESEARCH
Published on 24 Jan 2025
Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults
doi 10.3389/fphar.2025.1524702
- 308 views
ORIGINAL RESEARCH
Published on 10 Jan 2025
Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system
doi 10.3389/fphar.2024.1517546
- 579 views
ORIGINAL RESEARCH
Published on 06 Jan 2025
Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases
doi 10.3389/fphar.2024.1466875
- 672 views
ORIGINAL RESEARCH
Published on 03 Jan 2025
The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model
doi 10.3389/fphar.2024.1505653
- 267 views
ORIGINAL RESEARCH
Published on 18 Dec 2024
Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system
doi 10.3389/fphar.2024.1486422
- 777 views
ORIGINAL RESEARCH
Published on 11 Dec 2024
Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
doi 10.3389/fphar.2024.1502047
- 728 views
ORIGINAL RESEARCH
Published on 11 Dec 2024
A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system
doi 10.3389/fphar.2024.1438661
- 666 views
REVIEW
Published on 06 Dec 2024
Voriconazole: a review of adjustment programs guided by therapeutic drug monitoring
doi 10.3389/fphar.2024.1439586
- 592 views
ORIGINAL RESEARCH
Published on 21 Nov 2024
Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data
doi 10.3389/fphar.2024.1510220
- 556 views
Published in
Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Pharmacoepidemiology
- Pharmacology of Infectious Diseases
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 111kTopic views
- 68kArticle views
- 24kArticle downloads